Guyana: Health Officials Warned Against Bypassing New Drug Supply System in Guyana

President Dr. Irfaan Ali has issued a warning to health officials in Guyana regarding adherence to the new centralized medical supply system. During a meeting with Regional Health Officers (RHOs), hospital administrators, ministry officials, and Chief Medical Officer (CMO) Dr. Narine Singh, the President emphasized that any health officials who operate outside of this system may face dismissal.

The new platform is set to become the sole governing system for the distribution and management of drugs and medical supplies starting July 1. President Ali stated, “If you act outside of that, we have no other choice but to send you home,” highlighting the importance of following the clearly defined procedures and approval responsibilities established by the system.

Under the new arrangement, regions will no longer have the autonomy to independently purchase emergency drugs. Any such purchases will require approval from the Director of Regional Health Services, the CMO, and the head of the Materials Management Unit (MMU). This change aims to enhance accountability and minimize losses related to expired, damaged, or excess stock.

A monthly committee, which will include health officials such as the Minister of Health, Permanent Secretary, and Chief Pharmacist, will review emergency supply requirements across the country’s health system, including the Georgetown Public Hospital Corporation and regional hospitals. The President noted that emergency items, such as venom and antivenom, will be managed through the MMU.

He reiterated, “There is absolutely no situation where the regions must be purchasing emergency drugs unless there is a clear sign-off on the system.” The centralized platform is already operational and is set to replace all other systems on July 1.

Source: snn.gy